Meetings

The Gene Therapy Summit is an interactive meeting of representatives from academic and clinical centers, the biotechnology industry, ASTCT and additional collaborative professional societies focused on ex vivo gene therapy using hematopoietic stem cells.

The Toxicities of Transplantation and Cellular Therapies Conference brings together experts and thought leaders from around the world to discuss the mechanism of toxicities and symptom burden after hematopoietic cell transplantation (HCT) and cellular and gene therapies; current advances in the field; and best practices to both prevent and treat these toxicities and symptoms.

The webinar consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q & A session. In the September Journal Club session, Drs. Hosick and Robida will present two articles related to:

• CRISPR-Cas9 gene-edited allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in acute myeloid leukemia (AML)
• Azacitidine-venetoclax versus induction chemotherapy for the treatment of acute myeloid leukemia (AML)